Eledon Pharmaceuticals, Inc. (ELDN)
| Previous Close | 4.9600 |
| Open | 4.9100 |
| Bid | 4.7800 x 200 |
| Ask | 4.8700 x 200 |
| Day's Range | 4.6900 - 5.0000 |
| 52 Week Range | 1.1100 - 5.5400 |
| Volume | |
| Avg. Volume | 330,476 |
| Market Cap | 288.242M |
| Beta (5Y Monthly) | 0.77 |
| PE Ratio (TTM) | 10.72 |
| EPS (TTM) | 0.4500 |
| Earnings Date | Nov 12, 2024 - Nov 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.00 |
GlobeNewswireEledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Guggenheim Securities Inaugural Healthcare Innovation Conference on Wednesday, November 13, 2024, at 1:30 p.m. ET (10:30 a.m. PT). To register in advance for the presentation webcast, sign up here. A webcast replay will be accessible following the live session on th
- GlobeNewswire
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
IRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced the pricing of its underwritten offering of (i) 18,356,173 shares of its common stock at a price of $3.65 per share and (ii) pre-funded warrants to purchase up to an aggregate of 4,931,507 shares of common stock at a price of $3.649 per pre-funded warrant. The pre-funded warrants will be immediately exercisable and will have an exercise price of $0.001 per share. The gross pr
